Eversept Partners as of Sept. 30, 2024
Portfolio Holdings for Eversept Partners
Eversept Partners holds 67 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| GSK Sponsored Adr (GSK) | 11.4 | $166M | 4.1M | 40.88 | |
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 8.3 | $122M | 250k | 488.07 | |
| Natera (NTRA) | 7.6 | $111M | 870k | 126.95 | |
| Vera Therapeutics Cl A (VERA) | 6.2 | $91M | 2.1M | 44.20 | |
| Insmed Com Par $.01 (INSM) | 5.4 | $80M | 1.1M | 73.00 | |
| Syndax Pharmaceuticals (SNDX) | 5.4 | $79M | 4.1M | 19.25 | |
| PerkinElmer (RVTY) | 4.1 | $60M | 470k | 127.75 | |
| Inspire Med Sys (INSP) | 4.0 | $58M | 276k | 211.05 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.0 | $58M | 3.2M | 18.02 | |
| Community Health Systems (CYH) | 3.6 | $53M | 8.8M | 6.07 | |
| Bio-techne Corporation (TECH) | 3.6 | $53M | 664k | 79.93 | |
| Hca Holdings (HCA) | 3.6 | $53M | 129k | 406.43 | |
| United Therapeutics Corporation (UTHR) | 3.2 | $47M | 131k | 358.35 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 2.4 | $34M | 60k | 573.76 | |
| Zimvie (ZIMV) | 2.3 | $33M | 2.1M | 15.87 | |
| Healthequity (HQY) | 1.8 | $26M | 319k | 81.85 | |
| Repligen Corporation (RGEN) | 1.7 | $24M | 164k | 148.82 | |
| Viatris (VTRS) | 1.4 | $20M | 1.7M | 11.61 | |
| Protagonist Therapeutics (PTGX) | 1.4 | $20M | 445k | 45.00 | |
| Celldex Therapeutics Com New (CLDX) | 1.3 | $19M | 565k | 33.99 | |
| Ionis Pharmaceuticals (IONS) | 1.3 | $19M | 471k | 40.06 | |
| Miragen Therapeutics (VRDN) | 1.1 | $16M | 691k | 22.75 | |
| Mannkind Corp Com New (MNKD) | 0.9 | $13M | 2.0M | 6.29 | |
| Bausch Health Companies (BHC) | 0.9 | $13M | 1.5M | 8.16 | |
| Travere Therapeutics (TVTX) | 0.8 | $12M | 870k | 13.99 | |
| Humana (HUM) | 0.7 | $11M | 34k | 316.74 | |
| Danaher Corporation (DHR) | 0.7 | $11M | 38k | 278.02 | |
| Centene Corporation (CNC) | 0.7 | $10M | 135k | 75.28 | |
| Anthem (ELV) | 0.7 | $10M | 20k | 520.00 | |
| Fortrea Hldgs Common Stock (FTRE) | 0.6 | $9.2M | 458k | 20.00 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $9.1M | 125k | 73.17 | |
| Evolus (EOLS) | 0.5 | $7.3M | 453k | 16.20 | |
| Biohaven (BHVN) | 0.5 | $6.6M | 133k | 49.97 | |
| Arcutis Biotherapeutics (ARQT) | 0.4 | $6.4M | 693k | 9.30 | |
| Sutro Biopharma (STRO) | 0.4 | $6.4M | 1.8M | 3.46 | |
| Brookdale Senior Living (BKD) | 0.4 | $5.8M | 861k | 6.79 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.3 | $5.1M | 307k | 16.60 | |
| Paragon 28 (FNA) | 0.3 | $5.0M | 749k | 6.68 | |
| Gossamer Bio (GOSS) | 0.3 | $4.9M | 5.0M | 0.99 | |
| 2seventy Bio Common Stock | 0.3 | $4.7M | 998k | 4.72 | |
| Karyopharm Therapeutics | 0.3 | $4.6M | 5.5M | 0.83 | |
| Avantor (AVTR) | 0.3 | $4.4M | 168k | 25.87 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $4.1M | 535k | 7.60 | |
| Icon SHS (ICLR) | 0.3 | $3.9M | 14k | 287.31 | |
| Kura Oncology (KURA) | 0.3 | $3.8M | 192k | 19.54 | |
| Molina Healthcare (MOH) | 0.2 | $3.6M | 11k | 344.56 | |
| Merus N V (MRUS) | 0.2 | $3.4M | 68k | 49.96 | |
| Staar Surgical Com Par $0.01 (STAA) | 0.2 | $3.4M | 91k | 37.15 | |
| Puma Biotechnology (PBYI) | 0.2 | $3.3M | 1.3M | 2.55 | |
| Zai Lab Adr (ZLAB) | 0.2 | $3.3M | 135k | 24.14 | |
| Zenas Biopharma (ZBIO) | 0.2 | $3.2M | 191k | 16.92 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.2 | $3.2M | 778k | 4.11 | |
| Iqvia Holdings (IQV) | 0.2 | $3.1M | 13k | 236.97 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.2 | $2.8M | 337k | 8.31 | |
| Xoma Royalty Corporation Com New (XOMA) | 0.2 | $2.5M | 94k | 26.48 | |
| Inflarx Nv (IFRX) | 0.2 | $2.5M | 1.6M | 1.53 | |
| Tourmaline Bio (TRML) | 0.1 | $2.2M | 84k | 25.71 | |
| Amarin Corp Spons Adr New | 0.1 | $2.1M | 3.3M | 0.63 | |
| Nevro (NVRO) | 0.1 | $1.8M | 314k | 5.59 | |
| Alector (ALEC) | 0.1 | $1.6M | 333k | 4.66 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $1.5M | 407k | 3.63 | |
| Liquidia Corporation Com New (LQDA) | 0.1 | $1.4M | 138k | 10.00 | |
| Absci Corp (ABSI) | 0.1 | $1.0M | 273k | 3.82 | |
| Aerovate Therapeutics (AVTE) | 0.1 | $1.0M | 485k | 2.09 | |
| Stoke Therapeutics (STOK) | 0.0 | $639k | 52k | 12.29 | |
| Affimed N V Ordinary Shs New (AFMDQ) | 0.0 | $559k | 167k | 3.36 | |
| Ac Immune Sa SHS (ACIU) | 0.0 | $375k | 99k | 3.78 |